About AccuMedical
AccuMedical is a company based in Santa Ana (United States) founded in 2016. AccuMedical has raised $14.28 million across 3 funding rounds from investors including Taikang Insurance Group, Sequoia Capital and Huagai Capital. AccuMedical operates in a competitive market with competitors including Newronika, NovaVision, MindAffect, EnClear Therapies and Actipulse Neuroscience, among others.
- Headquarter Santa Ana, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.28 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Taikang Insurance Group
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AccuMedical
AccuMedical has successfully raised a total of $14.28M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AccuMedical
AccuMedical has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Taikang Insurance Group, Sequoia Capital and Huagai Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for AccuMedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AccuMedical
Investment portfolio details for AccuMedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AccuMedical
Detailed financials for AccuMedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accumedical Comparisons
Peer comparison for AccuMedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AccuMedical
AccuMedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newronika, NovaVision, MindAffect, EnClear Therapies and Actipulse Neuroscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices for neurodegenerative diseases are developed.
|
|
| Locked | Locked | Locked |
Non-invasive devices are developed for vision restoration in stroke survivors.
|
|
| Locked | Locked | Locked |
Brain-computer interface headsets are developed for patient communication.
|
|
| Locked | Locked | Locked |
Developer of device-based therapies to treat neurodegenerative disorders
|
|
| Locked | Locked | Locked |
Non-invasive brain stimulation technology is developed for neurodegenerative disorders.
|
Detailed competitors of AccuMedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accumedical
Complete news archive for AccuMedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AccuMedical
AccuMedical was founded in 2016 and raised its 1st funding round 3 years after it was founded.
AccuMedical is headquartered in Santa Ana, United States. It is registered at Santa Ana, California, United States.
AccuMedical is a funded company, having raised a total of $14.28M across 3 funding rounds to date.
AccuMedical was founded in 2016 and is headquartered in Santa Ana, United States. Neurovascular interventional devices are developed by the company for treating neurological disorders, including neurovascular malformation, cerebral aneurysm, ischemic stroke, and aneurysm conditions. Operations focus on device innovation within the medical technology sector, with a domain of accumedical.cn supporting global outreach. Various treatments are addressed through these specialized tools.
AccuMedical's top competitors include Newronika, NovaVision and Actipulse Neuroscience.
AccuMedical has 6 investors. Key investors include Taikang Insurance Group, Sequoia Capital, Huagai Capital, Proxima Ventures, and BioTrack Capital.